STRYPER frontman MICHAEL SWEET has shared an encouraging update on his battle with papillary thyroid cancer, telling fans during a June 26 Facebook Live session that his latest checkup brought good news. "Nothing has spread to my lymph nodes," the singer and guitarist said, adding that the cancer remains contained within healthy tissue.
SWEET was diagnosed last fall after a biopsy of a nodule on the right lobe of his thyroid. Papillary thyroid cancer accounts for roughly 80 percent of all thyroid cancer cases and carries the most favourable prognosis when caught early.
Rather than rushing into surgery, SWEET's medical team at Boston's Mass Eye and Ear has opted for active surveillance, wary that an operation could damage the vocal nerve running close to the tumour — a serious risk for a singer of SWEET's calibre. His next checkup is scheduled around nine months out. Doctors, he said, gave "very good" odds that the slow-growing cancer would remain unchanged into his late seventies or early eighties.
The vocalist has prior history here: in December 2023 he underwent a partial thyroidectomy to remove the left half of his thyroid, which contained a malignant nodule, without harming his voice. He also candidly addressed age-related vocal changes, including stiffening folds and tremors that prescribed medication has failed to ease.
Health scares aside, SWEET remains prolific. STRYPER issued the Christmas album "The Greatest Gift Of All" in November 2025, following 2024's "When We Were Kings," while his solo record "The Master Plan" arrived April 3, 2026. The famously devout musician also told fans he hopes to launch regular online prayer-group sessions, stressing the value of community and faith through difficult times.